S14 E02 Developing Disease Modifying Therapeutics for ALS at Neuropeutics
Update: 2025-07-10
Description
Marc Shenouda, CEO and Co-Founder of Neuropeutics Inc., gives insights into targeted therapeutics for neurodegenerative disease, winning the AbbVie Biotech Innovator’s Award, and earlier detection for ALS.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Comments
In Channel